These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27347115)

  • 1. Spontaneous hematoma in the setting of dual anti-platelet therapy with ticagrelor: A case report.
    Feng C; Wang L; Wang L
    Oncol Lett; 2016 Jul; 12(1):144-146. PubMed ID: 27347115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor-induced Angioedema After Percutaneous Coronary Intervention in a Patient with a History of Ischemic Stroke and Low Response to Clopidogrel: A Rare Dilemma.
    Piranavan P; Kaur NJ; Marmoush F; Burton A; Hannan J
    Cureus; 2018 Dec; 10(12):e3720. PubMed ID: 30891370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor.
    Cheng VE; Oppermen A; Natarajan D; Haikerwal D; Pereira J
    Heart Lung Circ; 2014 Apr; 23(4):e115-7. PubMed ID: 24480082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design.
    Kim C; Hong SJ; Shin DH; Kim BK; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Am Heart J; 2019 Jun; 212():45-52. PubMed ID: 30933857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.
    Franzone A; McFadden E; Leonardi S; Piccolo R; Vranckx P; Serruys PW; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; Diletti R; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Steg PG; Heg D; Jüni P; Windecker S; Valgimigli M;
    J Am Coll Cardiol; 2019 Nov; 74(18):2223-2234. PubMed ID: 31672177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome.
    Grifoni E; Paniccia R; Giusti B; Sticchi E; Padeletti L; Cavallini C; Marcucci R
    J Cardiol Cases; 2015 Sep; 12(3):65-67. PubMed ID: 30524542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAPT Plus Cilostazol is Better Than Traditional DAPT or Aspirin Plus Ticagrelor as Elective PCI for Intermediate-to-Highly Complex Cases: Prospective, Randomized, PRU-Based Study in Taiwan.
    Chen YC; Lin FY; Lin YW; Cheng SM; Lin RH; Chuang CL; Sheu JS; Chen SM; Chang CC; Tsai CS
    Am J Cardiovasc Drugs; 2019 Feb; 19(1):75-86. PubMed ID: 30467686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet agent-induced spontaneous liver hematoma.
    Darwish OS; Iqbal E
    Ann Pharmacother; 2012 Nov; 46(11):e33. PubMed ID: 23073305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminal narrowing due to intramural hematoma shift from left anterior descending coronary artery to left circumflex artery.
    Hirose M; Kobayashi Y; Kreps EM; Stone GW; Moussa I; Leon MB; Moses JW
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):461-5. PubMed ID: 15274154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
    Vranckx P; Valgimigli M; Jüni P; Hamm C; Steg PG; Heg D; van Es GA; McFadden EP; Onuma Y; van Meijeren C; Chichareon P; Benit E; Möllmann H; Janssens L; Ferrario M; Moschovitis A; Zurakowski A; Dominici M; Van Geuns RJ; Huber K; Slagboom T; Serruys PW; Windecker S;
    Lancet; 2018 Sep; 392(10151):940-949. PubMed ID: 30166073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
    Parker WA; Storey RF
    Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse alveolar hemorrhage associated with low molecular weight heparin and dual anti-platelet therapy after percutaneous coronary intervention.
    Yıldırım F; Kara İ; Okuyan H; Abacı A; Türkoğlu M; Aygencel G
    Clin Respir J; 2017 Nov; 11(6):1071-1073. PubMed ID: 26784680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
    Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of a coronary intramural hematoma after blunt chest trauma.
    Park MR; Min MK; Ryu JH; Lee DS; Lee KH
    Ulus Travma Acil Cerrahi Derg; 2018 Jan; 24(1):78-81. PubMed ID: 29350374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
    Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A
    BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired Hemophilia A May Be Associated with Ticagrelor Therapy in a 52-Year-Old Man After a Recent Percutaneous Transluminal Coronary Angioplasty.
    Pasquino P; Canaparo R; Capello T; Deorsola B; Perazzolo L; Marengo C; Serpe L
    Clin Med Insights Case Rep; 2016; 9():79-81. PubMed ID: 27660505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
    Baber U; Dangas G; Cohen DJ; Gibson CM; Mehta SR; Angiolillo DJ; Pocock SJ; Krucoff MW; Kastrati A; Ohman EM; Steg PG; Badimon J; Zafar MU; Chandrasekhar J; Sartori S; Aquino M; Mehran R
    Am Heart J; 2016 Dec; 182():125-134. PubMed ID: 27914492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.